Showing 41-50 of 3310 results for "".
Physician Spotlight: Gary Goldenberg, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-gary-goldenberg-md/20424/It's all hands on deck when building out a new dermatology practice.Physician Spotlight: Murad Alam, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-murad-alam-md/23172/Physician Spotlight: Dendy Engelman, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-dendy-engelman-md/20338/Today's minimally invasive procedures deliver big results. A specialist discusses what's possible.Physician Spotlight: Anne Chapas, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-anne-chapas-md/23390/Physician Spotlight: Michelle Henry, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-michelle-henry-md/23649/Physician Spotlight: Ellen Marmur, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-ellen-marmur-md/20581/Perspectives on head-to-toe beauty.Emerging Vitiligo Therapies
https://practicaldermatology.com/conferences/maui-derm-2022/emerging-vitiligo-therapies/20047/It’s really an exciting time to be treating vitiligo, says John E. Harris, MD, PhD. He reviews Phase 2 and 3 clinical trials for ruxolitinib, a topical JAK inhibitor, and the hope that the FDA could soon approve it for the treatment of vitiligo. He also discusses other possible targeted treatments iChanging Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysisSkin of Color Session: Dr. Harris
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/skin-of-color-session-dr-harris/32683/John E. Harris, MD, PhD, summarizes his vitiligo talk from the "Skin of Color Session" at Maui Derm 2025, during which he covered new therapeutic options for vitiligo as well as promising drugs in the pipeline and why they could be so impactful.Intergenerational Dermatology: Two Generations of Dermatologists Reflect on the Field
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatology-two-generations-of-dermatologists-reflect-on-the-field-2/23937/With Heidi A. Waldorf, MD, and Donald S. Waldorf, MD